BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO)

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Class B Common Stock
Shares outstanding
5,071,025
Total 13F shares
19,056,470
Share change
+65,910
Total reported value
$10,734,143,362
Put/Call ratio
146%
Price per share
$563.23
Number of holders
494
Value change
-$18,669,642
Number of buys
239
Number of sells
257

Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q1 2022

As of 31 Mar 2022, BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) was held by 494 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,056,470 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, FMR LLC, ALLIANCEBERNSTEIN L.P., BROWN ADVISORY INC, MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, and BANK OF AMERICA CORP /DE/. This page lists 501 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.